Drug-resistant Acinetobacter baumannii: From molecular mechanisms to potential therapeutics (Review)

被引:15
作者
Wu, Hao-Jia [1 ]
Xiao, Zhi-Gang [2 ]
Lv, Xiao-Juan [3 ,4 ,5 ]
Huang, Hai-Tang [3 ,4 ,5 ]
Liao, Chu [3 ,4 ,5 ]
Hui, Chen-Yang [3 ,4 ,5 ]
Xu, Yue [1 ]
Li, Heng-Fei [3 ,4 ,5 ]
机构
[1] Hubei Univ Chinese Med, Clin Coll Tradit Chinese Med, Wuhan 430065, Hubei, Peoples R China
[2] Hubei Prov Hosp Tradit Chinese Med, Dept Orthoped, Wuhan 430061, Hubei, Peoples R China
[3] Hubei Prov Hosp Tradit Chinese Med, Dept Hepatol, Hubei Key Lab Theory & Applicat Res Liver & Kidney, Room 4, Garden Hill, Wuhan 430061, Hubei, Peoples R China
[4] Hubei Univ Chinese Med, Affiliated Hosp, Dept Infect, Wuhan 430061, Hubei, Peoples R China
[5] Hubei Prov Acad Tradit Chinese Med, Dept Infect, Wuhan 430074, Hubei, Peoples R China
关键词
Acinetobacter baumannii; drug resistance; treatment; antibiotics; COLONIZATION; ANTIBIOTICS; INCREASE;
D O I
10.3892/etm.2023.11908
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Bacterial drug resistance is increasingly becoming an important problem that needs to be solved urgently in modern clinical practices. Infection caused by Acinetobacter baumannii is a serious threat to the life and health of patients. The drug resistance rate of Acinetobacter baumannii strains is increasing, thus research on the drug resistance of Acinetobacter baumannii has also seen an increase. When patients are infected with drug-resistant Acinetobacter baumannii, the availability of suitable antibiotics commonly used in clinical practices is becoming increasingly limited and the prognosis of patients is worsening. Studying the molecular mechanism of the drug resistance of Acinetobacter baumannii is fundamental to solving the problem of drug-resistant Acinetobacter baumannii and potentially other 'super bacteria'. Drug resistance mechanisms primarily include enzymes, membrane proteins, efflux pumps and beneficial mutations. Research on the underlying mechanisms provides a theoretical basis for the use and development of antibiotics and the development of novel treatment methods.
引用
收藏
页数:10
相关论文
共 107 条
  • [1] Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
    Abbey, Taylor
    Vialichka, Alesia
    Jurkovic, Michele
    Biagi, Mark
    Wenzler, Eric
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (03):
  • [2] Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens
    Abdul-Mutakabbir, Jacinda C.
    Alosaimy, Sara
    Morrisette, Taylor
    Kebriaei, Razieh
    Rybak, Michael J.
    [J]. PHARMACOTHERAPY, 2020, 40 (12): : 1228 - 1247
  • [3] Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii
    Amin, Mansour
    Navidifar, Tahereh
    Shooshtari, Farkhondeh Saleh
    Goodarzi, Hamed
    [J]. INFECTION AND DRUG RESISTANCE, 2019, 12 : 1171 - 1180
  • [4] The combination of CipA and PBP-7/8 proteins contribute to the survival of C57BL/6 mice from sepsis of Acinetobacter baumannii
    Badmasti, Farzad
    Habibi, Mehri
    Firoozeh, Farzaneh
    Fereshteh, Sepideh
    Bolourchi, Negin
    Goodarzi, Narjes Noori
    [J]. MICROBIAL PATHOGENESIS, 2021, 158
  • [5] Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii
    Baginska, Natalia
    Pichlak, Anna
    Gorski, Andrzej
    Jonczyk-Matysiak, Ewa
    [J]. VIROLOGICA SINICA, 2019, 34 (04) : 347 - 357
  • [6] Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
    Bartal, Carmi
    Rolston, Kenneth V., I
    Nesher, Lior
    [J]. INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 683 - 694
  • [7] Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features
    BergogneBerezin, E
    Towner, KJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) : 148 - +
  • [8] A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features
    Boral, Baris
    Unaldi, Ozlem
    Ergin, Alper
    Durmaz, Riza
    Eser, Ozgen Koseoglu
    Zarakolu, Pinar
    Ersoz, Gulden
    Kaya, Ali
    Haciseyitoglu, Demet
    Ak, Oznur
    Gencer, Serap
    Sariguzel, Fatma Mutlu
    Celik, Ilhami
    Uyanik, Muhammet Hamdullah
    Ozden, Kemalettin
    Acikgoz, Ziya Cibali
    Guner, Rahmet
    Akcali, Alper
    Sener, Alper
    Adiloglu, Ali
    Bulut, Cemal
    Yalinay, Meltem
    Dizbay, Murat
    Aydemir, Sohret
    Sipahi, Oguz Resat
    [J]. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2019, 18 (1)
  • [9] Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase
    Bouza, Alexandra A.
    Swanson, Hollister C.
    Smolen, Kali A.
    VanDine, Alison L.
    Taracila, Magdalena A.
    Romagnoli, Chiara
    Caselli, Emilia
    Prati, Fabio
    Bonomo, Robert A.
    Powers, Rachel A.
    Wallar, Bradley J.
    [J]. ACS INFECTIOUS DISEASES, 2018, 4 (03): : 325 - 336
  • [10] Acinetobacter baumannii maintains its virulence after long-time starvation
    Chapartegui-Gonzalez, Itziar
    Lazaro-Diez, Maria
    Bravo, Zaloa
    Navas, Jesus
    Icardo, Jose M.
    Ramos-Vivas, Jose
    [J]. PLOS ONE, 2018, 13 (08):